Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosomepositive acute lymphoblastic leukemia
J. H. Yoon, H. Y. Yhim, J. Y. Kwak, J. S. Ahn, D. H. Yang, J. J. Lee, S. J. Kim, J. S. Kim, S. J. Park, C. W. Choi, H. S. Eom, S. K. Park, S. Y. Choi, S. H. Kim, D. W. Kim, S. Lee
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosomepositive acute lymphoblastic leukemia'. Together they form a unique fingerprint.